Mikroscan Technologies
Private Company
Total funding raised: $3.3M
Overview
Mikroscan Technologies is a private medical device company developing compact, dual-mode digital pathology and live telemicroscopy systems. Its core technology addresses critical inefficiencies in traditional pathology by enabling remote, real-time slide review and digital archiving, targeting both clinical telemicroscopy and research/education markets. The company is revenue-generating, with a commercial-stage product portfolio focused on improving diagnostic access, pathologist workflow, and patient care in underserved areas.
Technology Platform
Integrated hardware/software platform for dual-mode live robotic telemicroscopy (for clinical use) and digital whole-slide imaging (for research/education). Features compact, affordable systems with real-time remote control and slide scanning/archiving capabilities.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Mikroscan competes in the digital pathology and telepathology market against large corporations like Roche (Ventana), Philips, and Leica Biosystems, as well as other specialized scanners. It differentiates on price, portability, and its unique dual-mode (live telemicroscopy + digital pathology) functionality, targeting cost-sensitive and remote settings.